B-type natriuretic peptide-guided therapy for chronic heart failure reduces all-cause mortality compared with usual care but does not affect all-cause hospitalisation or survival free of hospitalisation.
Richards
A Mark
AM
Cardioendocrine Research Group, University of Otago, Christchurch, New Zealand. mdcarthu@nus.edu.sg